Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Diabetes Mellitus, Date of authorisation: 25/06/2020, Revision: 4, Status: Authorised
TO: